Jenkins Jessica N

Konstas Anastasios G P, Kozobolis Vassilios P, Katsimpris Ioannis E, Boboridis Kostantinos, Koukoula Stavrenia, Jenkins Jessica N et al.

Latanoprost and travoprost similarly lowered 24-hour IOP in exfoliative glaucoma, though travoprost showed slightly better late-afternoon control but more hyperemia, guiding personalized treatment choices.

Konstas Anastasios G P, Topouzis Fotis, Leliopoulou Orea, Pappas Theofanis, Georgiadis Nikolaos, Jenkins Jessica N et al.

This study found that trabeculectomy provides superior 24-hour intraocular pressure control (lower mean, peak, and range) compared to maximum medical therapy in advanced glaucoma patients, highlighting surgical benefits beyond office hours.

Konstas Anastasios G P, Mikropoulos Dimitrios, Kaltsos Kostantinos, Jenkins Jessica N, Stewart William C

This study found travoprost effectively lowers IOP regardless of morning or evening dosing, but evening dosing provided slightly better daytime IOP control and less fluctuation, suggesting a marginal clinical benefit.

Konstas Anastasios G P, Katsimbris John M, Lallos Nikolaos, Boukaras George P, Jenkins Jessica N, Stewart William C

This study compared latanoprost and bimatoprost in POAG patients. Bimatoprost showed a statistically lower 24-hour IOP, but the difference was small and potentially not clinically significant, with more hyperemia than latanoprost.

Stewart William C, Jackson Angi L, Jenkins Jessica N

Patients often believe they can guess their eye pressure (IOP), usually based on symptoms. However, this study found most were inaccurate, and their guesses were no better than patients who didn't try.